GLOBUS MEDICAL INC GMED
GLOBUS MEDICAL INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($54.25); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
GLOBUS MEDICAL INC trades at about 21.9× earnings — below its 10-year norm (10-year range 23.1×–123.6×, median 41.9×).
Shaded band = 10-year range (23.1×–123.6×); dot = today's 21.9×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | 65.1% | 74.2% | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% |
| Operating margin | 16.3% | 6.6% | 8.5% | 22.3% | 17.9% | 14.1% | 21.9% | 23.7% | 25.4% | 27.3% |
| Net margin | 18.3% | 4.1% | 7.8% | 18.6% | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% |
| FCF margin | 20.0% | 16.1% | 10.5% | 10.2% | 22.9% | 17.1% | 12.9% | 17.1% | 16.9% | 19.0% |
| Return on assets | 10.1% | 2.0% | 2.4% | 9.2% | 7.6% | 6.1% | 10.1% | 12.0% | 10.0% | 11.2% |
| Return on equity | 11.8% | 2.5% | 3.1% | 10.3% | 8.6% | 6.8% | 11.1% | 13.2% | 11.1% | 12.5% |
| Current ratio | 4.26 | 2.54 | 4.88 | 6.18 | 6.17 | 6.80 | 6.17 | 6.56 | 6.67 | 6.43 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.